logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Breast Neoplasms

    FiltersReset Filters
    69 results
    • anastrozole

      (Anastrozole Tablets)
      Upsher-Smith Laboratories, LLC
      Usage: Anastrozole is indicated for the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for first-line and second-line treatments of locally advanced or metastatic breast cancer. It is effective following disease progression after tamoxifen therapy.
    • anastrozole

      (Anastrozole)
      Natco Pharma Limited
      Usage: Anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, as well as for first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer. It is also used as a second-line treatment for advanced breast cancer after tamoxifen therapy.
    • capecitabine

      (Capecitabine)
      Areva Pharmaceuticals
      Usage: Capecitabine is indicated for adjuvant treatment of Dukes’ C colon cancer post-surgery and as a first-line treatment for metastatic colorectal carcinoma. It is also used with docetaxel for metastatic breast cancer after prior anthracycline failure and as monotherapy for resistant metastatic breast cancer.
    • capecitabine

      (capecitabine)
      BluePoint Laboratories
      Usage: Capecitabine is indicated for the treatment of various cancers, including Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal cancer, advanced or metastatic breast cancer, and unresectable or metastatic gastric and pancreatic cancers, often in combination with other chemotherapy agents.
    • capecitabine

      (CAPECITABINE)
      NorthStar RxLLC
      Usage: Capecitabine is indicated for adjuvant treatment of Dukes' C colon cancer post-surgery and as first-line therapy for metastatic colorectal carcinoma. It is also used in combination with docetaxel for metastatic breast cancer after anthracycline failure, or as monotherapy for patients resistant to paclitaxel and anthracyclines.
    • capecitabine

      (Capecitabine)
      Aurobindo Pharma Limited
      Usage: Capecitabine tablets are indicated for the treatment of Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal cancer, advanced or metastatic breast cancer, unresectable gastric or esophageal cancers, and as adjuvant therapy for pancreatic adenocarcinoma in combination with chemotherapy regimens.
    • capecitabine 150mg

      (Capecitabine)
      Armas Pharmaceuticals Inc.
      Usage: Capecitabine tablets are indicated for adjuvant treatment of Dukes' C colon cancer post-surgery and as first-line therapy for metastatic colorectal carcinoma. They are also used for metastatic breast cancer after anthracycline failure, both in combination with docetaxel and as monotherapy for resistant cases.
    • cardiolite

      (TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE)
      Lantheus Medical Imaging, Inc.
      Usage: CARDIOLITE® is indicated for myocardial imaging to detect coronary artery disease, localizing ischemia and infarction to inform patient management. MIRALUMA® is indicated for planar breast imaging as a second-line diagnostic tool for evaluating abnormal mammograms or palpable masses, but not for screening or confirming breast cancer.
    • cyclophosphamide

      (Cyclophosphamide for Injection)
      Slate Run Pharmaceuticals, LLC
      Usage: Cyclophosphamide for Injection is indicated for treating various malignancies, including malignant lymphomas, multiple myeloma, leukemias, and solid tumors like breast cancer and ovarian adenocarcinoma. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome unresponsive to corticosteroid therapy.
    • cyclophosphamide

      (cyclophosphamide injection, solution)
      Baxter Healthcare Corporation
      Usage: Cyclophosphamide Injection is indicated for treating malignant lymphomas, multiple myeloma, various leukemias, advanced mycosis fungoides, disseminated neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is often used alone or in combination with other antineoplastic agents.
    • ...